Safety and Efficacy of Autologous or Donor-derived CD19 CAR-T Treatment in Relapsed B Acute Lymphocytic Leukemia after Allo-HSCT

被引：0
|
作者：
Zhang, Xian [1 ]
Lu, Xin-An [2 ]
Xiong, Min [1 ]
Yang, Jun-Fang [1 ]
Zhang, Jian-Ping [1 ]
Zhou, Xiao-Su [1 ]
He, Ting [2 ]
Lu, Pei-Hua [1 ]
机构：
[1] Hebei Yanda Ludaopei Hosp, Langfang, Peoples R China
[2] Immuno China Pharmaceut Co Ltd, Beijing, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O144
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [31] Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
    Dai, Hanren
    Zhang, Wenying
    Li, Xiaolei
    Han, Qingwang
    Guo, Yelei
    Zhang, Yajing
    Wang, Yao
    Wang, Chunmeng
    Shi, Fengxia
    Zhang, Yan
    Chen, Meixia
    Feng, Kaichao
    Wang, Quanshun
    Zhu, Hongli
    Fu, Xiaobing
    Li, Suxia
    Han, Weidong
    ONCOIMMUNOLOGY, 2015, 4 (11):
  • [32] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [33] Safety and Efficacy of CD19 CAR T-Cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement
    Jacoby, Elad
    Ghorashian, Sara
    Vormoor, Britta Julia
    De Moerloose, Barbara
    Bodmer, Nicole
    Maschan, Michael
    Yanir, Asaf David
    Bielorai, Bella
    Rogosic, Srdan
    Molostova, Olga
    Rossig, Claudia
    Toren, Amos
    Von Stackelberg, Arend
    Bourquin, Jean-Pierre
    BLOOD, 2020, 136
  • [34] Outcomes of Second Anti-CD19 CAR T-Cell Therapy (CART2) in Acute B Lymphoblastic Leukemia and the Impact of Allo-HSCT on Efficacy
    Xu, Qianwen
    Shi, Yi
    Xue, Lei
    An, Furun
    Xu, Hui
    Liu, Xin
    Zhu, Xiaoyu
    Sun, Zimin
    Zhai, Zhimin
    Wang, Xingbing
    CELL TRANSPLANTATION, 2023, 32
  • [35] Naturally selected CD7-directed CAR-T bridging allo-HSCT in refractory acute myeloid leukemia: a case report and review
    Liu, Xuan
    Xu, Zheng
    Li, Shuhui
    Zhang, Xuejun
    Li, Jianqiang
    Li, Hang
    Wang, Fuxu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Clinical Validation of Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of B Neoplasia
    Kerbauy, Lucila
    Coa, Larissa Leggieri
    Sielski, Micheli Severo
    Preto Godoy, Juliana Aparecida
    Kondo, Andrea Tiemi
    Cottas Azevedo, Julia Teixeira
    Barbosa, Augusto
    Okamoto, Oswaldo Keith
    Kutner, Jose Mauro
    Hamerschlak, Nelson
    Alves Paiva, Raquel de Melo
    BLOOD, 2022, 140 : 4930 - 4930
  • [37] Efficacy and Safety of CD28-or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia
    Zhao, Xiangyu
    Yang, Junfang
    Zhang, Xian
    Lu, Xin-An
    Xiong, Min
    Zhang, Jianping
    Zhou, Xiaosu
    Qi, Feifei
    He, Ting
    Ding, Yanping
    Hu, Xuelian
    De Smet, Floris
    Lu, Peihua
    Huang, Xiaojun
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 272 - 281
  • [38] allo-HSCT后复发/难治性B-ALL患者行CD19 CAR-T治疗的疗效及安全性
    黄成莹
    顾康生
    陶千山
    安福润
    翟志敏
    现代医药卫生, 2023, 39 (16) : 2701 - 2706
  • [39] SAFETY AND EFFICACY COMPARISON OF HUMANIZED CD19 CAR-T VERSUS BLINATUMOMAB THERAPY FOR RELAPSED/REFRACTORY B-ALL PATIENTS
    Wang, Kexin
    Jiang, Songfu
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2024, 59 : 199 - 200
  • [40] Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial
    Luo, Yi
    Gao, Lei
    Liu, Jia
    Yang, Luxin
    Wang, Lu
    Lai, Xiaoyu
    Gao, Shichun
    Liu, Lizhen
    Zhao, Lu
    Ye, Yishan
    Wang, Manning
    Shen, Lianjun
    Cao, W. William
    Wang, Dongrui
    Li, Wenling
    Zhang, Xi
    Huang, He
    ECLINICALMEDICINE, 2024, 67
12345